PSTX logo

Poseida Therapeutics (PSTX) Cash From Financing

Annual CFF

$16.13 M
-$89.03 M-84.66%

December 31, 2023


Summary


Performance

PSTX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPSTXcash flowmetrics:

Quarterly CFF

$742.00 K
+$742.00 K+100.00%

September 30, 2024


Summary


Performance

PSTX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPSTXcash flowmetrics:

TTM CFF

$699.00 K
-$14.20 M-95.31%

September 30, 2024


Summary


Performance

PSTX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPSTXcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

PSTX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-84.7%0.0%0.0%
3 y3 years-94.9%0.0%0.0%
5 y5 years-70.2%0.0%0.0%

PSTX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-84.7%-84.4%-99.0%-105.8%-99.3%at low
5 y5-year-94.9%-84.4%-99.6%-105.8%-99.8%at low
alltimeall time-94.9%-84.4%-99.6%-105.8%-99.8%at low

Poseida Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$742.00 K(>+9900.0%)
$699.00 K(-95.3%)
Jun 2024
-
$0.00(-100.0%)
$14.90 M(0.0%)
Mar 2024
-
-$43.00 K(<-9900.0%)
$14.90 M(-7.6%)
Dec 2023
$16.13 M(-84.7%)
$0.00(-100.0%)
$16.13 M(-0.4%)
Sep 2023
-
$14.94 M(>+9900.0%)
$16.18 M(-79.0%)
Jun 2023
-
$0.00(-100.0%)
$77.08 M(-0.0%)
Mar 2023
-
$1.19 M(+1944.8%)
$77.11 M(-26.7%)
Dec 2022
$105.16 M(+4076.3%)
$58.00 K(-99.9%)
$105.16 M(-0.2%)
Sep 2022
-
$75.84 M(>+9900.0%)
$105.34 M(+236.0%)
Jun 2022
-
$32.00 K(-99.9%)
$31.35 M(-0.1%)
Mar 2022
-
$29.23 M(>+9900.0%)
$31.39 M(+1146.6%)
Dec 2021
$2.52 M
$236.00 K(-87.3%)
$2.52 M(+8.5%)
DateAnnualQuarterlyTTM
Sep 2021
-
$1.85 M(+2668.7%)
$2.32 M(-98.9%)
Jun 2021
-
$67.00 K(-81.4%)
$206.99 M(-33.2%)
Mar 2021
-
$360.00 K(+847.4%)
$309.95 M(-1.3%)
Dec 2020
$313.94 M(+91.0%)
$38.00 K(-100.0%)
$313.94 M(+0.0%)
Sep 2020
-
$206.53 M(+100.5%)
$313.92 M(+172.4%)
Jun 2020
-
$103.03 M(+2270.6%)
$115.25 M(+58.3%)
Mar 2020
-
$4.35 M(>+9900.0%)
$72.80 M(-55.7%)
Dec 2019
$164.37 M(+204.0%)
$14.00 K(-99.8%)
$164.37 M(+0.0%)
Sep 2019
-
$7.86 M(-87.0%)
$164.36 M(+5.0%)
Jun 2019
-
$60.58 M(-36.8%)
$156.49 M(+63.2%)
Mar 2019
-
$95.92 M
$95.92 M
Dec 2018
$54.07 M(+162.1%)
-
-
Dec 2017
$20.63 M
-
-

FAQ

  • What is Poseida Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Poseida Therapeutics?
  • What is Poseida Therapeutics annual CFF year-on-year change?
  • What is Poseida Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Poseida Therapeutics?
  • What is Poseida Therapeutics quarterly CFF year-on-year change?
  • What is Poseida Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Poseida Therapeutics?
  • What is Poseida Therapeutics TTM CFF year-on-year change?

What is Poseida Therapeutics annual cash flow from financing activities?

The current annual CFF of PSTX is $16.13 M

What is the all time high annual CFF for Poseida Therapeutics?

Poseida Therapeutics all-time high annual cash flow from financing activities is $313.94 M

What is Poseida Therapeutics annual CFF year-on-year change?

Over the past year, PSTX annual cash flow from financing activities has changed by -$89.03 M (-84.66%)

What is Poseida Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of PSTX is $742.00 K

What is the all time high quarterly CFF for Poseida Therapeutics?

Poseida Therapeutics all-time high quarterly cash flow from financing activities is $206.53 M

What is Poseida Therapeutics quarterly CFF year-on-year change?

Over the past year, PSTX quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is Poseida Therapeutics TTM cash flow from financing activities?

The current TTM CFF of PSTX is $699.00 K

What is the all time high TTM CFF for Poseida Therapeutics?

Poseida Therapeutics all-time high TTM cash flow from financing activities is $313.94 M

What is Poseida Therapeutics TTM CFF year-on-year change?

Over the past year, PSTX TTM cash flow from financing activities has changed by $0.00 (0.00%)